Concepedia

A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients

Aurélie Moreau, Delphine Kervella, Laurence Bouchet‐Delbos, Cécile Braudeau, Soraya Saïagh, Pierrick Guérif, Sophie Limou, Sylvain Bercegeay, Mathias Streitz, Birgit Sawitzki,

Kidney International · 2022 · 37 citations · 27 references

DOIFull text

Open access

Concepts

References

27

Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survivalin vivo

Manfred B. Lutz, Rakesh M. Suri, Masanori Niimi et al. · European Journal of Immunology · 2000 · 468 citations

, , +10

Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance

Hēth Turnquist, Giorgio Raimondi, Alan F. Zahorchak et al. · The Journal of Immunology · 2007 · 425 citations

, , +17

Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients

Nick Giannoukakis, Brett E. Phillips, David N. Finegold et al. · Diabetes Care · 2011 · 399 citations · Full text

, , +17

Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients

Helen Benham, Hendrik J. Nel, Soi Cheng Law et al. · Science Translational Medicine · 2015 · 371 citations

, , +17

COSTIMULATORY MOLECULE-DEFICIENT DENDRITIC CELL PROGENITORS (MHC CLASS II+, CD80dim, CD86-) PROLONG CARDIAC ALLOGRAFT SURVIVAL IN NONIMMUNOSUPPRESSED RECIPIENTS12

Fumin Fu, Youping Li, Shiguang Qian et al. · Transplantation · 1996 · 367 citations

, , +15